Mayne Pharma Group Ltd

HG6

Company Profile

  • Business description

    Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women’s Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women’s Health segment distributes branded women’s health products in the U.S. International’s segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.

  • Contact

    1538 Main North Road
    Salisbury South
    SalisburySA5106
    AUS

    T: +61 882092666

    https://www.maynepharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Distribution

    Fiscal Year End

    30 June 2026

    Employees

    160

Stocks News & Analysis

stocks

Investors cheer Guzman dialing back global ambitions

Our view after US restaurants are closed.
stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.
stocks

Poor organic growth obscured by acquisition for ASX listed share

Sales dropped by 2% without impact of acquisition.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,915.1035.500.40%
CAC 408,115.7529.750.37%
DAX 4024,888.56281.791.15%
Dow JONES (US)50,579.70294.040.58%
FTSE 10010,466.2622.790.22%
HKSE25,606.03219.510.86%
NASDAQ26,343.9750.870.19%
Nikkei 22565,288.911,949.843.08%
NZX 50 Index13,037.2345.920.35%
S&P 5007,473.4727.750.37%
S&P/ASX 2008,693.7037.600.43%
SSE Composite Index4,112.9035.620.87%

Market Movers